RNA silencing suppressors (RSSs) are well studied for plant viruses but are not well defined to date for animal viruses. Here, we have identified an RSS from a medically important positive-sense mammalian virus, Severe acute respiratory syndrome coronavirus. The viral 7a accessory protein suppressed both transgene and virus-induced gene silencing by reducing the levels of small interfering RNA (siRNA). The suppression of silencing was analyzed by two independent assays, and the middle region (amino acids [aa] 32 to 89) of 7a was responsible for suppression. Finally, the RNA suppression property and the enhancement of heterologous replicon activity by the 7a protein were confirmed for animal cell lines.
RNA silencing processes restrict viral proliferation and disease manifestation (4, 8, 15) . To overcome this antiviral response, viruses have evolved to encode RNA silencing suppressors (RSSs) (46) . For plant viruses, RSSs were first described as pathogenicity factors that contribute to high levels of virus accumulation and disease (2, 23) . Though the majority of RSS proteins have been identified in plant viruses, only a few are reported to occur in animal viruses. Some of the best-studied mammalian virus RSSs are NS1 of influenza A virus (7, 29) , VP35 of Ebola virus, E3L of vaccinia virus, Tat of HIV-1, NSs of La Crosse virus, C of hepatitis C virus, and Tas of primate foamy virus 1 (19, 38, 42) . Thus, screening methods need to be developed for identification of novel RSSs in animal viruses.
Severe acute respiratory syndrome coronavirus (SARS-CoV) is one of the highly infectious positive-stranded RNA viruses that spread worldwide and killed hundreds of people in early 2003 (9) . Since SARS-CoV generates abundant double-stranded RNA (dsRNA) as replicative and transcriptive intermediates (24) , this virus is likely to induce and become a target of gene silencing. Although animal viruses may experience gene silencing onslaught differently from plant viruses (5) , we examined whether the SARS-CoV could encode an RSS protein(s) like other positive-strand RNA viruses (30, 31, 45) . SARS-CoV contains 8 unique open reading frames (ORFs) that are pre-dicted to encode proteins contributing toward viral replication and pathogenesis (26, 27, 43, 47) . SARS-CoV leads to a gradual increase of viral load in the first 10 days postinfection (dpi), and no type I interferon response is observed, despite the onset of viral replication and viral protein synthesis (12, 26) . Though early activation of innate immune pathways in SARS-CoV patients is possible, the role of RSSs in immune evasion and interferon agonist activity cannot be ruled out (10, 34) .
Since RSSs act in a cross-kingdom fashion, we subjected the viral ORFs to a plant-based RSS screening test (22) . These assays have an edge over the mammalian ones, as there are no overlapping immune and interferon-responsive pathways (6, 13, 41) . The 7a accessory protein, along with another ORF (3a), was targeted as a candidate RSS protein. 7a induces apoptosis in a caspase-dependent manner (44), blocks cell cycle progression at G 0 /G 1 phase, induces cell cycle arrest (48) , inhibits cellular protein synthesis but not transcription and nucleoplasmic transport, and activates p38MAPK but not c-Jun and N-terminal protein kinases (25) . For the RSS assay, two known viral RSSs, namely, Mungbean yellow mosaic India virus (MYMIV) AC2 and Flock house virus (FHV) B2, were included as positive controls (40) .
The reversal-of-silencing assay and the replication-based spot assay (22) were applied to screen the SARS-CoV ORFs. All necessary ORFs (7a, 3a, AC2, and B2) were cloned into the plant binary vector pBI121 (Fig. 1A) . The reversal-of-silencing assay was carried out with green fluorescent protein (GFP)silenced transgenic Nicotiana xanthi lines by agroinfiltrationmediated transient ectopic expression of ORFs in leaf tissues. Infiltrated leaves were analyzed for reversal of GFP activity at 8 days postinfiltration. Only the 35S 7a-infiltrated zones (and not 3a) showed GFP fluorescence like the two positive controls, namely, FHV B2 and MYMIV AC2 ( Fig. 1B) . Interestingly, the ectopic expression of 7a led to reduction of biogen-esis of small interfering RNA (siRNA) (17, 18, 49) , as evident from the small RNA Northern blot ( Fig. 2C , middle). In fact, similar reduction has also been reported for many RSSs, viz., the reovirus sigma 3, hepatitis C virus core, and FHV B2 proteins (11, 32, 40) . Reduction in siRNA level was associated with corresponding increases in GFP-mRNA and -protein levels (Fig. 1C) .
The viral RNAs also show RSS activity (3). Adenovirusassociated (VA) RNAs I and II serve as the competitive substrate squelching the Dicer enzyme (3), which in turn affects the normal biogenesis of siRNA. To determine whether the 7a protein or the 7a RNA possesses the RSS activity, we generated a site-specific deletion mutation in the 7a gene to introduce a premature stop codon after the N-terminal 3rd amino acid and the downstream frameshift mutation. This mutant was designated 35S 7a ⌬C123TGA . This mutant mRNA was similar to wild-type (wt) 35S 7a ( Fig. 2B , left panel, top row) but failed to show reversal of silencing ( Fig. 2A and 3A ). In the 35S 7a ⌬C123TGA -infiltrated patches, no GFP fluorescence ( Fig. 2A ) or reduction in siRNA levels was observed ( Fig. 2B , left panel, middle row, and right panel). Therefore, the 7a protein, not the RNA, was essential for suppression of RNA silencing.
An alternative method for observing the RSS activity involved conducting functional complementation of an established RSS (37) . Thus, using MYMIV-based viral amplicon mutated for the RSS AC2 ( Fig. 2A) (22, 39) VA AC2M , we analyzed the 7a RSS activity. 35S 7a, upon coinfiltration with VA AC2M in a wild-type tobacco (Nicotiana tabacum cv. Petit Havana) plant, was able to rescue the amplicon accumulation ( Fig. 2C ) in trans to approximately the same extent as the control RSSs, i.e., MYMIV AC2 and FHV B2 (Fig.  2D ). The amplicon accumulation was generally diminished by host RNA silencing activity and was quantitated by measuring the intensity of the 1.6-kb PCR band when the PCR was carried out for 26 cycles using the divergent primers (the locations of which are marked at the bottom of Fig. 2C ) (35, 39) . Thus, 35S 7a was able to suppress the virus-induced gene silencing activated against the viral amplicon during in planta replication as well.
SARS-CoV 7a encodes a 122-amino-acid protein, and we wanted to decipher the region important for its RSS activity. Our deletion mutation analysis showed that both the N-terminal (SARS-CoV 7a ⌬63-122 ) and the C-terminal (SARS-CoV 7a ⌬1-55 ) halves were capable of independently showing RSS activity ( Fig. 3A and B ). The contribution of two halves of a protein for the same biochemical activity has been reported for many proteins earlier (16, 28) . Moreover, on further deletion, the peptide fragment containing amino acids [aa] 32 to 89 (35S 7a ⌬1Ϫ31ϩ⌬90Ϫ122 ) ( Fig. 3B ) has also been found to be somewhat essential for the RSS activity. This region primarily constitutes the compact immunoglobulin-like ␤-sandwich fold (20, 23) of 7a. However, further studies need to be initiated to establish this structure-function correlation. Further, the deletion mutants, namely, 35S 7a ⌬48-122 and 35S 7a ⌬1-71 , failed to show any suppression activity ( Fig. 3A and B) , indicating that (Fig. 3 ). Finally, we confirmed the RSS activity of the 7a protein in animal cell lines. A bicistronic gene vector (RNAi-Ready-pSIREN-RetroQ-ZsGreen, abbreviated Retro-Q; Clonetech, CA) that encodes the GFP under cytomegalovirus (CMV) and the short hairpin RNA (shRNA) under the U6 promoter was used for the reporter assay. In this vector, shRNA for luciferase (an unrelated shRNA control) was cloned for control experiments. The transfection of the Retro-Q vector in HEK293T cells resulted in almost 90% cells showing green fluorescence while the control cells showed no fluorescence, as expected. The expression of shRNA against GFP (nucleotide [nt] positions 973 to 994) resulted in reduction of GFP-expressing cells by 79%. This reporter plasmid DNA with shRNA-GFP (0.5 g in 1 ml) was cotransfected either with an increasing concentration of the 7a plasmid or with the control RSS, viz., FHV B2 (Fig. 4A) . Cotransfection dramatically restored the number of GFP-expressing cells in a 7a dose-dependent fashion (Fig. 4A, both right and left panels) . The same was also true when 1 g of FHV B2-expressing plasmid was used.
We also examined whether 7a could increase the animal viral replicon activity, similar to those seen in Fig. 2D . Hence, we used an HIV-1 reporter gene-based replicon assay system employing the full-length HIV-1 genome-containing luciferase reporter gene (pNL-LucR-E; obtained from NIH AIDS Research & Reference Reagent, MD) (21) (Fig. 4B) . The firefly luciferase gene was inserted into the pNL4-3 (infectious HIV-1 DNA) Nef gene to yield pNL4-3.LucR-E-(pNL-Luc). The extent of luciferase reporter gene activity was directly proportional to the extent of HIV-1 replication. HEK293T/A549 cells were cotransfected with a fixed amount of pNL-Luc (0.1 g in 1 ml for 1 ϫ 10 5 cells) by use of Lipofectamine along with an increasing concentration of SARS-CoV 7a-encoding plasmid DNA for 48 h. The cells were lysed in 100 l of lysis buffer, and the reporter activity was measured with a luminometer. A dose-dependent increase in luciferase activity, i.e., HIV replicon activity, was observed (Fig. 4C ). Similar enhancement was also observed with the NS1 protein of influenza A virus, a known RSS. A strikingly similar result, i.e., 7a-mediated enhancement of HIV replicon activity, was observed when the SARS-CoV-permissive A549 cells were used for transfection experiments (Fig. 4D) . A control dual reporter gene plasmid (pTK-RL) was used to normalize transfection efficiency in the entire transfection-based assay. The results shown in Fig. 4C and D are representative of three independent experiments. A similar type of enhancement of the HIV replicon by the RSS activity of HIV Tat (19) , rice hoja blanca virus NS3 protein (37) , and influenza virus NS1 protein (14) has been reported earlier. These results suggest that the 7a protein of SARS-CoV might help the viral genome replicate efficiently in vivo, defying the host RNA interference (RNAi)-mediated degradative action toward the replicating viral genome. With the availability of the SARS-CoV replicon, this hypothesis could be put to test and thus the 7a protein could become an important drug target.
Collectively, the above-mentioned experiments establish that SARS-CoV 7a is a potent suppressor of siRNA activity in mammalian cells, including the SARS-CoV-permissive lung carcinoma cells. Its localization in the endoplasmic reticulum (36) , where viral dsRNA replicative and transcriptive intermediates also exist (24) , also suggests its potential role in protecting the virus from the host RNA silencing mechanism during infection. Moreover, the previously reported loss of virus accumulation upon inactivation of ORF 7 (1) can now be ascribed to the RSS activity of 7a. Thus, the 7a protein of highly pathogenic SARS-CoV has probably evolved to counter the host RNA silencing mechanism, in addition to showing various other biological activities (43, 44) .
